FDA Law Blog: Biosimilars

FEBRUARY 26, 2024

This of course, make sense—after decades of experience implementing the Hatch-Waxman, Congress and FDA had learned a few new tricks by 2009/2010. Amongst other things, FDA co-opted many of the same definitions for key terms for implementation of the BPCIA. mL), to be biosimilar to or interchangeable with High Concentration Humira (e.g.,

FDA 59

FDA Biosimilars Production Regulations 59

The Pharma Data

MARCH 16, 2021

In partnering with the Lieber Institute, Boehringer Ingelheim has in-licensed preclinical pipeline candidates, representing a first-in-class approach for targets in neuropsychiatric disorders. The potential of centrally acting COMT inhibitors has not yet been evaluated in the clinic due to the unavailability of such compounds.

Licensing 52

Licensing Licensing Research Laboratories Treatment 52

Drug Target Review

FEBRUARY 28, 2024

Prior to that, Mr Ho was at New Leaf Venture Partners, a leading healthcare venture capital firm, where he launched and managed the public investments and cross-over portfolio, and served as its Public Investment Director from 2010 to 2014. Normality sensing licenses local T cells for innate-like tissue surveillance.

Therapies 105

Therapies Engineering Molecular Biology Science 105

The Pharma Data

MARCH 29, 2022

Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Sanofi has also expressed an interest in purchasing up to $100M of IGM non-voting common stock in a public financing. About IGM Biosciences, Inc.

Engineering 52

Engineering Clinical Trials Licensing Licensing 52

The Pharma Data

JANUARY 12, 2021

From 2010 to 2020, Dr Graham was VP of Strategic Program Direction, Immunology and Inflammation at Regeneron Pharmaceuticals, Inc., Multiple IND’s, NDA/BLA filings and/or defense and multiple successful launches.

Science 52

Science Clinical Development Disease Production 52

Agency IQ

APRIL 26, 2024

BY RACHEL COE, MSC | APR 24, 2024 10:56 PM CDT Biosimilars and interchangeable products The FDA was first authorized to develop a pathway for the approval of biosimilar products in 2010 under the Biologics Price Competition and Innovation (BPCI) Act. The reactions to this shift in policy were varied.

Biosimilars 40

Biosimilars Science FDA Licensing 40

The Pharma Data

FEBRUARY 25, 2021

Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac , its tick-borne encephalitis (TBE) vaccine for active immunization to prevent TBE in individuals 1 year of age and older. 2010 Jun 23;28(29):4558-65. NEW YORK–(BUSINESS WIRE)– Pfizer Inc.

FDA 52

FDA Vaccine Virus Clinical Trials 52

The Pharma Data

APRIL 4, 2023

“Since receiving FDA clearance in 2010, more than 17 million CoolSculpting® treatments have been performed. As with any medical procedure, a consultation should be done by a licensed healthcare professional to determine if the patient is a candidate for treatment. 3 Our patient satisfaction research shows that 89.2%

Treatment 40

Treatment FDA Licensing Licensing 40

Drug Target Review

AUGUST 9, 2024

She has co-founded three biotech companies in Asia and Europe and worked as a senior consultant and board member for multiple biotech projects helping to facilitate licensing and investments internationally. References Allen, L. Popovich, N. G., & Ansel, H. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems (9th ed.).

Science 59

Science Drugs Compliance Drug Development 59

Codon

JANUARY 21, 2024

We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. But in 2010, this guy participating in a challenge trial in Oxford committed sexual assault and then ran from the law and was a fugitive, while participating in this study.

Vaccine 111

Vaccine Trials Disease Treatment 111

Agency IQ

AUGUST 25, 2023

BY CHELSEY MCINTYRE, PHARMDAUG 18, 2023 4:19 PM CDT Regulatory Context: Biosimilars and Interchangeability The FDA was first authorized to develop a pathway for the approval of biosimilar products in 2010 under the Biologics Price Competition and Innovation (BPCI) Act.

Biosimilars 40

Biosimilars FDA Production Licensing 40

Codon

FEBRUARY 27, 2024

In 2010, seven members of a soccer team in Oregon were infected with norovirus after touching a reusable grocery bag, which was covered in viral particles, and then eating the food inside. A startup that makes such a spray has gained an EPA license to sell its product to customers in the consumer, commercial, and healthcare sectors.

Virus 68

Virus Hospitals Production Regulations 68

Agency IQ

JUNE 2, 2023

These prototypes, and the intended form and function of a PMI for prescription drugs, were further refined in a series of workshops with the Brookings Institute between 2010 and 2014. However, only licensed blood establishments would be required to submit PMI to FDA for approval.”

FDA 40

FDA FDA Approval Production Regulations 40

Codon

MARCH 28, 2023

We estimate that roughly 3 percent of all DARPA projects, since 2010, have been neurotechnological in some way. ” Another company, called Kernel , was also interested in the hippocampal memory prosthesis technology, according to Song, and licensed some of the IP.

Engineering 52

Engineering Research Science FDA Approval 52

The Pharma Data

NOVEMBER 15, 2020

In addition, Dr. Lee Babiss, a committed director since 2010, has announced his retirement and has stepped down from the board. This prestigious group of professionals will help lead the Company as it prepares for potential commercialization of its investigational cell therapy, MultiStem ®.

Clinical Trials 40

Clinical Trials Trials Production Therapies 40

The Pharma Data

OCTOBER 14, 2020

It was granted orphan drug designation for the treatment of narcolepsy in 2010. Food and Drug Administration in August 2019 for the treatment of excessive daytime sleepiness in adult patients with narcolepsy and has been commercially available in the U.S. since Q4 2019. WAKIX is a selective histamine 3 (H?)

FDA Approval 40

FDA Approval FDA Treatment Clinical Trials 40

The Pharma Data

MAY 13, 2021

The Executive Director of the Institute for Behavior Change (IBC), licensed psychologist and certified school psychologist Steve Kossor, has been involved in the planning and delivery of what became known as Intensive Behavioral Health Services (IBHS) in Pennsylvania since 1981. push(arguments)},i[r].l=1*new Want to work with us? Click here.

Treatment 52

Treatment Production Licensing Licensing 52

Codon

JULY 27, 2023

A company, Agragene , has now started greenhouse tests with this technology (it’s licensed from Synvect, a spin-out from Omar Akbari’s lab at the University of California, San Diego). When a gene-edited female lays her eggs, then, the female offspring never hatch, and the males hatch but can’t produce offspring of their own.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

A company, Agragene , has now started greenhouse tests with this technology (it’s licensed from Synvect, a spin-out from Omar Akbari’s lab at the University of California, San Diego). When a gene-edited female lays her eggs, then, the female offspring never hatch, and the males hatch but can’t produce offspring of their own.

Therapies 52

Therapies RNA DNA Engineering 52

The Pharma Data

AUGUST 3, 2021

In July, the FDA accepted the Biologics License Application and granted Priority Review for tezepelumab for the treatment of asthma. Tax Court to contest notices of deficiencies received from the IRS during the quarter for 2010, 2011 and 2012. Tezepelumab. Regulatory reviews are also underway in the EU and Japan. Tax Petition.

Biosimilars 52

Biosimilars Production Treatment FDA 52

Codon

JANUARY 2, 2024

But the jury’s decision wasn’t the only blow dealt to Rainin: The company also lost their exclusive license to sell Gilson pipettes in the United States, which cost Rainin an estimated $19 million in lost revenue. 2 Eppendorf, a German medical supply company, purchased an exclusive license. Micropipette innovators.

Laboratories 111

Laboratories DNA Licensing Licensing 111

The Pharma Data

MAY 15, 2023

5 GSK’s MenABCWY vaccine candidate combines the antigenic components of licensed meningococcal vaccines, Bexsero and Menveo. In the US, Bexsero is licensed under the Accelerated Approval pathway for active immunisation to prevent IMD caused by Neisseria meningitidis serogroup B in individuals from 10 through 25 years.

Vaccine 40

Vaccine Immune Response Licensing Licensing 40

Agency IQ

SEPTEMBER 1, 2023

The MHRA notes that the new pathway will be parallel to its innovation pathway (the Innovative Licensing and Access Pathway , or ILAP), which integrates “early regulatory advice with health technology assessment advice.” In May 2023, the MHRA revealed which regulators will be included in the scheme: Australia, Canada, the E.U.,

International 40

International Regulations Production Marketing 40

Agency IQ

JUNE 16, 2023

Final Rule Stage Clean Water Act Section 401: Water Quality Certification 2040-AG12 August 2023 Clean Water Act (CWA) section 401 provides States and Tribes with a powerful tool to protect the quality of their waters from adverse impacts resulting from federally licensed or permitted projects.

Regulations 40

Regulations Compliance Production Science 40

Agency IQ

JULY 12, 2024

Proposed Rule Pediatric Study Plan Requirements for New Drug and Biologics License Applications October 2024 FDA is proposing to amend its existing regulations and add new regulations pertaining to submission of required initial pediatric study plans (iPSPs) under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Regulations 40

Regulations FDA Science Production 40

Codon

AUGUST 10, 2023

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Nature Reviews Genetics (2010). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Nucleic Acids Research (2010). Science (2010).

DNA 92

DNA Cell Biology Molecular Biology Engineering 92

LifeSciVC

OCTOBER 28, 2024

In-licensing molecules from other players, due to a partner’s strategic shifts, budget challenges, or geographic access, can be a great way to jumpstart early stage companies around more advanced assets. That deal catalyzed it’s next financing and IPO… but the asset eventually failed.

Licensing 90

Licensing Licensing Marketing Targeted Protein Degradation 90

Codon

AUGUST 10, 2023

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Nature Reviews Genetics (2010). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Science (2010).

DNA 52

DNA Cell Biology Engineering Molecular Biology 52

FDA Law Blog: Biosimilars

OCTOBER 24, 2024

By 2010, about 2000 isolated human genes had been patented in the U.S. In 2010, the Association for Molecular Pathology (AMP), among other organizations, brought suit against Myriad Genetics, challenging the validity of the company’s patents on the BRCA 1/2 genes.

Laboratories 64

Laboratories DNA Testimonials Biosimilars 64

Drug & Device Law

JULY 31, 2023

Dental Organization for Conscious Sedation, LLC , 2010 WL 5146603, at *2-3 (E.D. 13, 2010) (whether “education, information, and protocols” were products could not be decided on the pleadings). However, licensed software can be a UCC sale of “goods.” “[N]either the Michigan Products Liability Statute nor the common law. . .

Production 52

Production Trials International Government 52

Drug & Device Law

FEBRUARY 20, 2023

Without an FDA license to produce another design, [defendant] was legally prohibited from distributing either [alternative design advocated by plaintiffs] at the time [plaintiff] received her vaccinations. As a result, appellee was prohibited by federal law from employing either of these [alternatives]. Wyeth Laboratories, Inc. ,

FDA 59

FDA FDA Approval Testimonials Vaccine 59

Drug & Device Law

OCTOBER 27, 2022

2010 WL 894054 (N.D. From this, the court concluded the defendants could “comply with both federal and Illinois law by obtaining proof of identity and establishing a donor identification system using photographic identification, a valid driver’s license, or any other non-biometric means.” Medtronic, Inc. , 3d 994 (S.D. Genzyme Corp.

FDA 59

FDA Licensing Licensing Regulations 59

Drug & Device Law

AUGUST 8, 2022

For qualified IMGs, it issues a certification, which IMGs can then use to apply to residency and other graduate medical education programs and to apply for state medical licenses. Smith, LLC , 2010 WL 11566367, at *7 (N.D. May 14, 2010) (“Defendant [standards institute’s] standards are voluntary, consensus standards, and Defendant. .

Production 52

Production Doctors Licensing Licensing 52

Drug & Device Law

MAY 30, 2022

The law presumes that licensed doctors know what they are doing. W]e believe that a drug manufacturer cannot be required legally to foresee that a licensed physician will disregard express warnings regarding a drug’s use. . . . 2010), vacated on other grounds , 88 A.3d 2010) (applying Pennsylvania law). 3d 572 (Pa.

Testimonials 59

Testimonials Doctors Production Laboratories 59

Drug & Device Law

MARCH 7, 2022

2010) (applying TwIqbal because “[p]unitive damages are never awarded as a matter of right, are disfavored by the law”). 2010) (other citations and quotation marks omitted). It does not give him license to evade the less rigid ? It does not, however, give a plaintiff “license to evade the less rigid ? Corrections Corp. ,

Licensing 59

Licensing Licensing Production FDA 59